Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-11-28
1986-08-05
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546122, A61K 3144, C07D47104
Patent
active
046043993
ABSTRACT:
4-R'-5-Q-1,6-naphthyridin-2(1H)-ones (I), where R' is hydrogen or methyl and Q is hydroxymethyl, 1-hydroxyethyl alkanoyloxymethyl or 1-alkanoyloxyethyl, are produced by first reacting 4-R'-5-acetyl(or n-propanoyl)-6-[2-(di-lower-alkylamino]-2(1H)-pyridinone [III] with hydroxylamine or salt thereof to produce 4-R'-5-Q'-1,6-naphthyridin-2(1H)-one-6-oxide (II), where R' is defined as above and Q' is methyl or ethyl; next reacting II with an alkanoic anhydride to produce I where Q is alkanoyloxymethyl or 1-alkanoyloxyethyl; and, then hydrolyzing said alkanoyloxymethyl or -ethyl compound to produce I where Q is hydroxymethyl or 1-hydroxyethyl. Also shown is the cardiotonic use of II and I where Q is hydroxymethyl, 1-hydroxyethyl or alkanoyloxymethyl.
REFERENCES:
Chemical Abstracts 72, 12,615d (1970).
Ogata et al. [Chem. Pharm. Bull. 20, 2264 (1972)].
Lesher George Y.
Singh Baldev
Bair Robert K.
Dentz Bernard I.
DuPont Paul E.
Jiles Henry R.
Sterling Drug Inc.
LandOfFree
5-methyl(or ethyl)-1,6-naphthyridin-2(1H)-one 6-oxides, their pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-methyl(or ethyl)-1,6-naphthyridin-2(1H)-one 6-oxides, their pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-methyl(or ethyl)-1,6-naphthyridin-2(1H)-one 6-oxides, their pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-969351